FDA Approves Marketing of Nicotine Pouches
Medically reviewed by Drugs.com.
By Stephanie Brown HealthDay Reporter
FRIDAY, Jan. 17, 2025 -- Following an extensive scientific review, the U.S. Food and Drug Administration has authorized the marketing of 20 ZYN nicotine pouch products. Nicotine pouches -- small synthetic fiber pouches containing nicotine -- are designed to be placed between a person's gum and lip.
Referencing the public health standard legally required by the 2009 Family Smoking Prevention and Tobacco Control Act, the FDA determined that due to substantially lower amounts of harmful constituents than cigarettes and most smokeless tobacco products, the authorized nicotine pouches pose a lower risk for cancer and other serious health conditions. In addition, there is evidence that these nicotine pouches can help current users of cigarettes and other tobacco products successfully quit these more harmful products.
"To receive marketing authorizations, the FDA must have sufficient evidence that the new products offer greater benefits to population health than risks," Matthew Farrelly, Ph.D., director of the Office of Science in the FDA Center for Tobacco Products, said in an agency news release. "In this case, the data show that these nicotine pouch products meet that bar by benefiting adults who use cigarettes and/or smokeless tobacco products and completely switch to these products."
The FDA emphasized this authorization does not mean the nicotine products are completely safe but that they meet the requirements for providing more benefit than harm. The agency added it will follow the marketing of these products closely to guard against marketing to youth and will enforce "stringent restrictions" on digital, television, and radio advertising.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2025-01-18 06:00
Read more

- Water, Plain Milk Are the Healthiest Drinks for Kids
- FDA Approves Symbravo (meloxicam and rizatriptan) for the Acute Treatment of Migraine with or without Aura in Adults
- Women Of Color Receive Slower Response To A Bad Mammogram
- Leukocyte Count Predictor of Future Long COVID Severity in Postmenopausal Women
- Minority Children Less Likely to Be Diagnosed With Migraine in Emergency Department
- HoLEP Double-n Technology Promising for Benign Prostatic Hyperplasia
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions